CORGENIX MEDICAL CORP/CO
10KSB, EX-27, 2000-10-02
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: CORGENIX MEDICAL CORP/CO, 10KSB, 2000-10-02
Next: EVERLERT INC, 10QSB, 2000-10-02



<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLARS

<S>                                               <C>
<PERIOD-TYPE>                                    12-MOS
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                  JUL-1-1999
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                          1
<CASH>                                                  47
<SECURITIES>                                             0
<RECEIVABLES>                                          618
<ALLOWANCES>                                             7
<INVENTORY>                                            551
<CURRENT-ASSETS>                                     1,209
<PP&E>                                               1,103
<DEPRECIATION>                                         470
<TOTAL-ASSETS>                                       2,290
<CURRENT-LIABILITIES>                                1,542
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                                17
<OTHER-SE>                                             (60)
<TOTAL-LIABILITY-AND-EQUITY>                         2,290
<SALES>                                              3,525
<TOTAL-REVENUES>                                     3,545
<CGS>                                                1,473
<TOTAL-COSTS>                                        3,071
<OTHER-EXPENSES>                                     1,723
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                     149
<INCOME-PRETAX>                                        200
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                                      0
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                           213
<EPS-BASIC>                                           0.01
<EPS-DILUTED>                                         0.01



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission